Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Jacob Chacko currently holds 50,000 shares of Oric Pharmaceuticals, Inc. (ORIC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jacob Chacko has been a net seller of ORIC stock. They have purchased $3.1M and sold $6.4M worth of shares.
Jacob Chacko's most recent insider trade was on Jun 17, 2026, when they sold 50,000 shares at $0.00 per share.
Jacob Chacko serves as Executive at Oric Pharmaceuticals, Inc. (ORIC). They have executed 66 insider transactions totaling $9.5M over their tenure at the company.
Jacob Chacko holds the position of Executive at Oric Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 12 years and currently hold a stake valued at $0.
Jacob Chacko has shown a selling trading pattern, with $3.1M in total purchases and $6.4M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Jacob Chacko was on Sep 22, 2025, when they sold $1.4M worth of ORIC shares. This transaction involved 125,000 shares at $10.80 per share.
Jacob Chacko currently owns 50,000 shares of Oric Pharmaceuticals, Inc. (ORIC), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Jacob Chacko's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Jacob Chacko has 66 Form 4 filings on record as an insider at Oric Pharmaceuticals, Inc..
Set alerts for Jacob Chacko and 40,000+ other insiders.